Related Experiment Video
Updated: Jun 20, 2026

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
Fecal shedding of SARS-CoV-2 in infants born to SARS-CoV-2 positive mothers: a pilot study
Dylan K P Blaufus1, Karen M Kalanetra1, Rosa Pesavento2
1Department of Food Science and Technology, University of California, Davis, CA, United States of America.
Background:
Fecal shedding of SARS-CoV-2 occurs during infection, particularly in pediatric populations. The gut microbiota are associated with resistance to enteric pathogens. COVID-19 is associated with alterations to the gut microbiome. We hypothesized that the gut microbiome of infants born to SARS-CoV-2+ mothers differs between infants with and without fecal shedding of the virus.
Methods:
We enrolled 10 infants born to SARS-CoV-2+ mothers. We used qPCR on fecal RNA to test for SARS-CoV-2 and 16S rRNA gene sequencing of the V4 region to assess the gut microbiome. Infant SARS-CoV-2 status from nasal swabs was abstracted from medical records.
Results:
Of the 10 included infants, nine were tested for SARS-CoV-2 by nasal swab with 1 testing positive. Four infants, including the nasal swab positive infant, had at least one sample with detectable levels of SARS-CoV-2 fecal shedding. Detection of both SARS-CoV-2 genes in feces was associated with increased gut alpha diversity compared to no detection by a linear mixed effects model (p < 0.001). Detection of both SARS-CoV-2 genes was associated with increased levels Erysipelotrichaceae, Lactobacillaceae, and Ruminococceae by MaAsLin2.
Conclusion:
Fecal shedding of SARS-CoV-2 occurs in infants who test negative on nasal swabs and is associated with differences in the gut microbiome.
Insights
Infants born to mothers with SARS-CoV-2 may shed the virus in feces, even with negative nasal swabs. This fecal shedding is linked to distinct gut microbiome compositions in infants.
Area of Science:
- Microbiology
- Virology
- Pediatrics
Background:
- Fecal shedding of SARS-CoV-2 is observed in infected individuals, especially children.
- Gut microbiota composition influences resistance to enteric pathogens.
- COVID-19 infection is known to alter the gut microbiome.
Purpose of the Study:
- To investigate differences in the gut microbiome of infants born to SARS-CoV-2 positive mothers, comparing those with and without detectable fecal virus shedding.
Main Methods:
- Fecal RNA was analyzed using qPCR to detect SARS-CoV-2.
- 16S rRNA gene sequencing of the V4 region was employed to characterize the gut microbiome.
- Infant SARS-CoV-2 status was confirmed via nasal swab results from medical records.
Main Results:
- SARS-CoV-2 fecal shedding was detected in four out of ten infants, including one infant who tested positive via nasal swab.
- Fecal SARS-CoV-2 detection correlated with increased gut alpha diversity (p < 0.001).
- Specific bacterial families, including Erysipelotrichaceae, Lactobacillaceae, and Ruminococceae, were more abundant in infants with fecal shedding.
Conclusions:
- SARS-CoV-2 can be shed in the feces of infants, even when nasal swabs are negative.
- Infant fecal shedding of SARS-CoV-2 is associated with significant alterations in gut microbiome composition.
Related Concept Videos
Parental Care
Single Nucleotide Polymorphisms-SNPs
Development of the Oral Microbiota
Coronavirus

